Clinical trial
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
NCT04592887 is registered in ClinicalTrials.gov with Varian, a Siemens Healthineers Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
- Lead sponsor
- Varian, a Siemens Healthineers Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 3, 2020
- Completion date
- March 27, 2023
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone metastasis